Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.3903
-0.0057 (-1.44%)
At close: May 13, 2026, 4:00 PM EDT
0.3945
+0.0042 (1.08%)
After-hours: May 13, 2026, 4:55 PM EDT
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$24,034
Profits / Employee
-$1,409,233
Market Cap
6.43M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 1 | 50.00% |
| Dec 31, 2021 | 2 | 1 | 100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| FibroBiologics | 15 |
| TransCode Therapeutics | 12 |
| Purple Biotech | 10 |
| XTL Biopharmaceuticals | 10 |
| Immuron | 7 |
| Akari Therapeutics, | 6 |
| Xenetic Biosciences | 2 |
| Addex Therapeutics | 2 |
SILO News
- 6 days ago - Silo Pharma files provisional patent for ibogaine-based therapeutics - TheFly
- 6 days ago - Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury - GlobeNewsWire
- 14 days ago - Silo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD - GlobeNewsWire
- 21 days ago - Silo Pharma expands into AI technology with Qwikagents asset purchase - TheFly
- 21 days ago - Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents - GlobeNewsWire
- 5 weeks ago - Silo Pharma gets European Patent Office allowance for PTSD prevention therapy - TheFly
- 5 weeks ago - Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy - GlobeNewsWire
- 2 months ago - Silo Pharma announces $1M share repurchase program - TheFly